STAT3 and neoplasm: In xenograft tumour models, reducing CD96 levels can accelerate mitochondrial fatty acid β‐oxidation by regulating the Src‐Stat3‐Opa1 signalling axis, thereby enhancing the resistance of breast CSCs to chemotherapy.231